MEMORANDUM OPINION
SULLIVAN, District Judge.
Six plaintiffs, known as John Doe # 1 through # 4 and Jane Doe # 1 and # 2, brought this action to challenge the lawfulness of the defendants’ Anthrax Vaccination Immunization Program (“AVIP”). Currently pending before the Court is plaintiffs’ motion for attorneys’ fees and costs. Upon consideration of the motion, the response and reply thereto, the applicable law, and the entire record, the Court determines that plaintiffs are entitled to attorneys’ fees, but that their pending request is flawed in several, significant aspects. Therefore, for the reasons stated herein, plaintiffs’ motion for attorneys’ fees and costs is DENIED without prejudice.
BACKGROUND
This Court set forth a detailed description of the case’s regulatory and procedural background in its 2004 opinion,
see Doe v. Rumsfeld,
341 F.Supp.2d 1, 3-8 (D.D.C. 2004), so it need only be summarized here. Pursuant to a process established for drugs whose regulation was transferred from the National Institutes of Health to the FDA, the FDA issued a proposed order concerning AVA in 1985.
Id.
at 4-6. The FDA panel, whose report was incorporated into the proposed order, concluded that AVA was safe and effective “under the limited circumstances for which it is employed.”
Id.
at 4-5. The panel did so after examining the “Brachman study,” which investigated AVA’s effectiveness against cutaneous anthrax and inhalation anthrax.
Id.
at 5. The proposed order recommended that AVA be placed in “Category I,” which encompassed drugs that are safe, effective, and not misbranded.
Id.
Pursuant to its regulations, the FDA published notice of the proposed rule and solicited comments for 90 days.
Id.
at 5-6. Following the receipt of comments, the
FDA took no further action until this suit was filed.
Id.
at 6.
In March 2003, plaintiffs filed suit in this Court, alleging that the AVIP violated federal law because AVA had never been approved as a safe and effective drug for protection against inhalation anthrax.
Id.
On December 22, 2003, the Court issued a preliminary injunction enjoining AVIP inoculations absent consent because the FDA had never issued a final decision regarding the safety of AVA.
Id.
Eight days later, the FDA issued a final order classifying AVA as a Category I drug, stating that it was effective regardless of the route of exposure.
Id.
The final order re-analyzed the data underlying the 1985 proposed order and also relied upon studies conducted after 1985.
Id.
at 7. Both parties subsequently moved for summary judgment, with plaintiff seeking permanent injunctive relief.
Id.
at 8.
On two initial matters, the Court determined the plaintiffs had standing and that the FDA’s December 2003 decision constituted an order, instead of a rule.
Id.
at 9-12. Even though the decision was an order, the Court concluded that because the FDA regulations required notice and comment for the order, the notice and comment must have been procedurally sufficient under the standards of the Administrative Procedure Act.
Id.
at 13. Utilizing the logical outgrowth doctrine, the Court concluded that the notice and comment for AVA was insufficient because the final order deviated too greatly from the proposed order.
Id.
at 15. Defendants had contended that the proposed order was substantively identical to the final order because the proposed order classified AVA as a Category I drug and did not limit its application to any particular route of exposure.
Id.
at 14. The Court, however, found that the scope of the proposed order’s recommendation did not include inhalation anthrax because the proposed order stated that there was insufficient data concerning AVA’s effectiveness against inhalation anthrax.
Id.
at 15. Therefore, the public was not on notice that AVA was being considered for use against inhalation anthrax specifically, and thus the FDA’s procedure did not provide a meaningful opportunity for comment as required by the FDA’s own regulations.
Id.
As a remedy, the Court vacated the final order and remanded it to the FDA for reconsideration.
Id.
at 16. In addition, the Court entered a permanent injunction enjoining defendants’ use of AVA absent consent until the FDA properly classified AVA as safe and effective for its intended purpose.
Id.
at 19.
While this case was on appeal, in December 2005, the FDA issued a new final order after a notice-and-comment period, explicitly finding AVA efficacious against inhalation anthrax.
See Biological Products; Bacterial Vaccines and Toxoids; Implementation of Efficacy Review; Anthrax Vaccine Adsorbed,
70 Fed.Reg. 75,-180 (Dec. 19, 2005). As a result, the D.C. Circuit held that this Court’s permanent injunction had dissolved by its own terms, dismissed the appeal as moot, and remanded the case to this Court for further proceedings.
Doe v. Rumsfeld,
172 Fed.Appx. 327 (D.C.Cir.2006) (per curiam). On remand, the only remaining issue is plaintiffs’ motion for attorneys’ fees and costs under the Equal Access to Justice Act (“EAJA”), 28 U.S.C. § 2412(d).
ANALYSIS
Plaintiffs have filed an application for $508,310.44 in attorneys’ fees and costs. Defendants first contend that plaintiffs are not entitled to any fees and costs because defendants’ position was substantially justified. In the alternative, defendants contend that the proper award is much less than plaintiffs’ request because (1) plain
tiffs are not prevailing parties with regard to their appeal to the D.C. Circuit; (2) plaintiffs’ requested rate for their counsel is above the statutory limit; and (3) plaintiffs’ purported billable hours are too high because they improperly seek reimbursement for certain activities and their billing records are too vague.
I. Substantial Justification
The EAJA provides that a prevailing party in a non-tort suit against the United States is entitled to fees and expenses unless the government’s position was “substantially justified.” 28 U.S.C. § 2412(d)(1)(A). The Supreme Court has held that a position is substantially justified “if a reasonable person could think it correct, that is, if it has a reasonable basis in law and fact.”
Pierce v. Underwood,
487 U.S. 552, 556, 108 S.Ct. 2541, 101 L.Ed.2d 490 (1988). The D.C. Circuit has stated that “the hallmark of the substantial justification test is reasonableness.”
Role Models Am., Inc. v. Brownlee,
353 F.3d 962, 967 (D.C.Cir.2004). The government bears the burden of establishing that its position was substantially justified.
F.J. Vollmer Co., Inc. v. Magaw,
102 F.3d 591, 595 (D.C.Cir.1996). Moreover, the government must demonstrate the reasonableness of both the agency’s actions as well as its litigation position.
Role Models,
353 F.3d at 967.
The question of reasonableness cannot be collapsed into the antecedent evaluation on the merits; it is a distinct legal standard.
F.J. Vollmer,
102 F.3d at 595. The court’s reasoning on the merits, however, may be quite instructive in resolving the substantial justification issue.
Id.
For instance, a finding on the merits that an agency’s decision lacked substantial evidence generally implies that the agency’s decision was unreasonable.
Id.
In addition, if an agency failed “to enforce a rule where it plainly applied,” it is much more likely that the agency’s decision was not substantially justified.
Id.
Defendants contend that their position, at both the agency level and during litigation, was reasonable because they reasonably construed the 1985 proposed order as encompassing approval of AVA for treating inhalation anthrax. In support of this position, defendants point out that the proposed order classified AVA as a Category I drug and did not limit its approval to a particular route of exposure. If this view of the proposed order was reasonable, then the agency’s procedures would have been proper because the 2003 final order would have been the logical outgrowth of the proposed order.
In the 2004 opinion, the Court concluded that the proposed order did not encompasses approval of AVA against inhalation anthrax, especially in the context of a potential biological attack as AVA is used in the AVIP.
Doe,
341 F.Supp.2d at 15. The Court reached this conclusion by focusing on two key statements in the proposed order. The first is that the proposed order found AVA safe and effective for the “limited circumstances” of its usage at that time, specifically inoculating individuals in certain industrial settings who worked with animal furs and hairs.
Id.
The second is that the proposed order, in analyzing the Brachman study, found that the lack of data permitted no meaningful analysis of the AVA’s effectiveness against inhalation anthrax.
Id.
Thus, the public was not on notice that AVA would be deemed safe and effective against inhalation anthrax.
Id.
The question of whether defendants’ litigation position was substantially justified is a close one. Even conceding that the Court’s analysis was correct, defendants make the argument that their view of the proposed order was still reasonable. They argue that because the pro
posed order did not explicitly limit its approval of AVA to any particular route of exposure, it is at least reasonable to interpret the proposed order as covering all routes of exposure. The Court, however, finds more persuasive the argument that the proposed order could not have meant to approve AVA for inhalation anthrax when it explicitly stated that it found no evidence to prove AVA’s effectiveness against inhalation anthrax. In fact, the 2003 final order had to directly contradict the scientific conclusions in the proposed order regarding the Brachman study in order to support the position that AVA was effective against inhalation anthrax.
See id.
at 7. Given the explicit qualifications in the proposed order and the reversal in analysis in the 2003 final order, the Court concludes that defendants’ litigation position was not substantially justified under the EAJA.
In addition, for the government’s position to be substantially justified, the agency’s actions also must have been reasonable.
Role Models,
353 F.3d at 967. Plaintiffs contend that the defendants’ actions were clearly unreasonable when they instituted the AVIP program without any final FDA order approving the usage of AVA.
See Doe v. Rumsfeld,
297 F.Supp.2d 119, 133-34 (D.D.C.2003) (concluding that AVIP program violated federal law and entering preliminary injunction because the FDA had not issued a final order and no study proved AVA’s effectiveness against inhalation anthrax). Rather than appeal the Court’s conclusions, the FDA abruptly altered course and issued a final order merely eight days after the Court’s 2003 opinion. Such a response is indicative of the unreasonableness of the agency’s initial stance. Given the unreasonableness of the agencies’ initial position before the lawsuit, and their sharp changes in December 2003 — issuing a final order after 18 years that contradicted the proposed order — the Court concludes that the government was not substantially justified in this case.
II. Prevailing Party Status
Defendants contend that plaintiffs cannot be considered a prevailing party with regard to the appeal to the D.C. Circuit. “Normally, a prevailing party is entitled to attorney’s fees for work done on appeal.”
Jean v. Nelson,
863 F.2d 759, 770 (11th Cir.1988). Some courts, though, have held that if plaintiffs “did not prevail on any legal issue or obtain any additional relief’ on appeal, then plaintiffs have not prevailed at that stage of the litigation.
Id.; see also Clark v. City of Los Angeles,
803 F.2d 987, 993 (9th Cir.1986) (holding that attorney’s fees should not be paid for appellate work when “nothing associated with the appeal contributed to [the] favorable result achieved by litigation”).
However, “the prevalent approach to determining whether a plaintiff is a prevailing party on appeal is to inquire whether the plaintiff has prevailed in the litigation as a whole.”
Schneider v. Colegio de Abogados de Puerto Rico,
187 F.3d 30, 48 (1st Cir.1999). Thus, one court in this district has rejected the idea of “bifurcating] a determination of whether plaintiffs prevailed on appeal from whether plaintiffs prevailed at trial for purposes of determining eligibility of fees.”
Dougherty v. Barry,
820 F.Supp. 20, 25 (D.D.C.1993). Instead, because plaintiffs ultimately prevailed on their claims, the court found plaintiffs “eligible for the reasonable fees and costs incurred on both the trial and appellate levels, including fees and costs incurred in defending on appeal specific issues which were ultimately decided against them.”
Id.
In support of this position as well is the statutory language, which speaks of awarding fees and costs to a prevailing party in a “civil action” and does distinguish between different stages
of the action.
See
28 U.S.C. § 2412(d)(1)(A);
Dougherty,
820 F.Supp. at 25.
In this case, there is no question that plaintiffs have prevailed overall as they achieved the permanent injunctive relief that they sought.
See Role Models, 353 F.3d
at 966 (holding that plaintiffs prevailed where they won an injunction that forestalled an agency’s action until the agency properly complied with relevant regulations). It is also clear that plaintiffs did not receive any additional relief on appeal, or an affirmation of their position, because the appeal was mooted by the government’s actions. Therefore, the question for the Court is whether awarding fees for plaintiffs’ work on appeal is “reasonable” given their overall prevailing party status.
See Hensley v. Eckerhart,
461 U.S. 424, 433, 103 S.Ct. 1933, 76 L.Ed.2d 40 (1983) (holding that once a party is determined to be prevailing, a court must decide what fees are “reasonable”).
The Court concludes that plaintiffs are entitled to fees and costs relating to the appeal. Plaintiffs were litigating on appeal the very same issues on which they succeeded in this Court. The reason plaintiffs did not further succeed on appeal is because defendants mooted the appeal by giving plaintiffs the exact result they sought: revised action by the FDA. If defendants intended to accede to plaintiffs, they could have saved plaintiffs the expense of litigating the appeal by simply not appealing this Court’s decision. As plaintiffs incurred additional expenses only because defendants unnecessarily pursued an appeal initially, it is reasonable that plaintiffs should be reimbursed for these expenses as they ultimately prevailed. Thus, the Court rejects defendants’ argument for reducing plaintiffs’ fees.
III. Proper Rate for Attorneys and Staff
Defendants contend that plaintiffs utilize an improperly high rate for calculating their attorneys’ fees. The EAJA specifically provides that “attorney fees shall not be awarded in excess of $125 per hour unless the court determines that an increase in the cost of living or a special factor, such as the limited availability of qualified attorneys for the proceedings involved, justifies a higher fee.” 28 U.S.C. § 2412(d)(2)(A). Defendants contend that all attorneys should be reimbursed no more than the EAJA maximum of $125 plus a cost of living adjustment.
Plaintiffs contend that their attorneys’ special qualifications entitle them to higher rates for fees. Specifically, plaintiffs rely on the their attorneys’ expertise in the combined areas of military justice, administrative law, and national security.
The Supreme Court has interpreted the EAJA’s rate clause narrowly, holding that enhanced rates are permitted only for “attorneys having some distinctive knowledge or specialized skill.”
Pierce,
487 U.S. at 572, 108 S.Ct. 2541. As examples, the Court has referred to “an identifiable practice specialty such as patent law, or knowledge of foreign law or language.”
Id.
The D.C. Circuit has interpreted this to mean that fee enhancement is available only for lawyers whose specialty “requir[es] technical or other education outside the field of American law.”
Waterman Steamship Corp. v. Maritime Subsidy Bd.,
901 F.2d
1119, 1124 (D.C.Cir.1990). The D.C. Circuit has also stated that expertise in administrative law in a particular area, such as communications, railroads, or firearms, does not entitle attorneys to enhanced fees under the EAJA.
F.J. Vollmer,
102 F.3d at 598-99. The Circuit has also rejected the claim that expertise in federal election law justifies a fee enhancement.
In re Sealed Case 00-5116,
254 F.3d 233, 236 (D.C.Cir. 2001). Finally, this Court has previously rejected the assertion that expertise in military administrative law is a basis for a fee enhancement.
Lynom v. Widnall,
222 F.Supp.2d 1, 6-7 (D.D.C.2002) (“Plaintiffs counsel’s extensive experience in military law is simply insufficient to warrant enhanced fees.”). Therefore, the Court concludes that plaintiffs are not entitled to attorneys’ fees more than the EAJA maximum of $125 plus a cost of living adjustment.
Adjusting the billable rates for plaintiffs’ attorneys will require an extensive recalculation of plaintiffs’ fee request. The Court will not undertake this endeavor, but instead will deny plaintiffs’ motion for attorneys’ fees without prejudice to reconsideration of an amended request in compliance with this opinion. As plaintiffs’ request suffers from additional flaws, the Court will provide further guidance for plaintiffs.
Plaintiffs have also sought fees for work done by legal assistants. Plaintiffs have the burden of justifying the rates for which these individuals are billed.
Role Models,
353 F.3d at 969-70. Plaintiffs, however, have not submitted any information about the relevant market rate and have “not even taken the basic step of submitting an affidavit detailing the non-attorneys’ experience and education.”
See id.
at 970. Plaintiffs are therefore required to justify the rates for the legal assistants in their amended fee request.
IV. Proper Accounting of Billable Hours and Costs
Under this Circuit’s law, plaintiffs have the burden of establishing the reasonableness of their fee request, and “supporting documentation must be of sufficient detail and probative value to enable the court to determine with a high degree of certainty that such hours were actually and reasonably expended.”
Role Models,
353 F.3d at 970. In assessing reasonableness, prevailing counsel “must make a good faith effort to exclude from a fee request hours that are excessive, redundant or otherwise unnecessary.”
Hensley,
461 U.S. at 434, 103 S.Ct. 1933. One disfavored practice is submitting time records that “lump together multiple tasks, making it impossible to review their reasonableness.”
Role Models,
353 F.3d at 971. Another flaw in time records is inadequate detail, such as records that only describe work as “research,” “writing,” or “participating in teleconference.”
Id.
Finally, duplication of effort is another basis on which fee requests can be deemed excessive.
Id.
at 972. Defendants contend that plaintiffs’ fee request suffers from all of these problems. In addition, defendants contend that plaintiffs’ requested billable hours must be reduced for a variety of specific reasons, each of are analyzed in turn.
A. Media Contacts
Defendants contend that 29.5 hours should deducted from plaintiffs’ request because they seek reimbursement for media contacts. “In this circuit, the government cannot be charged for time spent in discussions with the press.”
Role Models,
353 F.3d at 973. Plaintiffs concede this argument. Therefore, these hours should not be included in the amended fee request.
B. Travel Time
Defendants contend that 16 hours should deducted from plaintiffs’ request because they seek reimbursement for 32 hours of travel time. Travel is time is supposed to be compensated at half the attorney’s hourly rate.
See Cooper v. U.S. R.R. Retirement Bd.,
24 F.3d 1414, 1417 (D.C.Cir.1994). Plaintiffs concede this argument. Therefore, these hours should not be included in the amended fee request.
C. Admission to the Court
Defendants contend that 8.7 hours should deducted from plaintiffs’ request because they seek reimbursement for time spent seeking admission to this Court. A fee request cannot include such time because this Circuit has held that “the cost of joining the bar of this court [is] an expense of doing business not chargeable to clients — much less to the federal government.”
Role Models,
353 F.3d at 973. Plaintiffs concede this argument. Therefore, these hours should not be included in the amended fee request.
D. Recovery for Matters Outside the Litigation
Defendants contend that plaintiffs’ fee request inappropriately seeks reimbursement for matters outside this litigation. Plaintiffs are only entitled to fees and costs arising in this “civil action.” 28 U.S.C. § 2412(d)(1). Defendants specifically challenge plaintiffs’ requests for reimbursement for (1) work on a Seventh Circuit case, (2) work related to a separate FOIA lawsuit, and (3) work related to the notice-and-comment period that resulted in the FDA’s final order in 2005. This last request relates to work that occurred after this Court’s final judgment and appears more connected to plaintiffs’ separate litigation over the 2005 order.
See Doe v. Von Eschenbach,
06-2131-RMC (D.D.C.2006);
see also NAACP v. Donovan,
554 F.Supp. 715, 720 (D.D.C.1982) (indicating that fees are not available for work related to rulemaking proceedings). Therefore, unless they provide a convincing explanation, plaintiffs should not seek reimbursement for these matters in the amended fee request.
E. Work on an Unfiled Motion
Defendants contend that plaintiffs inappropriately seek reimbursement for work on a motion that was never filed. This motion was plaintiffs’ motion for an order to show cause why defendants should not be held in contempt for violating the Court’s permanent injunction. The work on this motion, totaling 31.3 hours, occurred in February 2005, after the Court’s permanent injunction was entered. Plaintiffs briefly claim that this work was necessary to preserve the integrity of the injunction.
Defendants argue that it is unreasonable to allow fees to be paid for this work because it may have been unnecessary. The needlessness of the work was potentially unrevealed because defendants never had the opportunity to oppose the motion. Plaintiffs have not refuted this possibility because they have not explained why the motion was necessary and yet never filed. Without such an explanation, the Court cannot fully evaluate the reasonableness of plaintiffs’ request. Therefore, unless they provide a fuller explanation, plaintiffs should not seek reimbursement for work on this motion in the amended fee request.
F. Clerical Matters
Defendants contend that plaintiffs inappropriately seek reimbursement for clerical or administrative work. Purely clerical or secretarial tasks, which do not require the skills of an attorney or legal assistant, cannot be included in a fee petition.
See Role Models,
353 F.3d at 973. Plaintiffs’
fee request includes numerous entries for updating files, downloading documents, and sending documents. Many of these tasks appear clerical or secretarial, and plaintiffs have not explained how the tasks require the skills of at least a paralegal. Therefore, unless they provide an explanation, plaintiffs should not seek reimbursement for this work in the amended fee request.
G. Attorney Zaid’s Vague Entries
Defendants contend that many billing entries for attorney Mark Zaid are too vague to allow the Court to evaluate their reasonableness. The D.C. Circuit has held that billing entries describing work only as “research,” “writing,” or “participating in teleconference” are inadequately detailed for fee petition purposes.
Id.
at 971. Many of Zaid’s entries describe his work only as “E-mails,” “Tel. conv” or “Online research.” Under the Circuit’s standard, these entries are clearly too vague. One possible remedy is to reduce plaintiffs’ fee by certain percentage because of the vague entries.
See id.
at 973 (allowing reimbursement for only fifty percent of the attorney hours that plaintiff requested because of “inadequate documentation, failure to justify the number of hours sought, inconsistencies, and improper billing entries”). Unless these entries are more detailed in plaintiffs’ amended fee request, the Court will utilize this remedy.
H. Excessive Time on Appeal
Defendants contend that plaintiffs seek excessive reimbursement for work related to the appeal. Plaintiffs retained twelve additional lawyers (besides the main attorneys — Zaid and John Michels) to work on the appeal and, by defendants’ calculation, devoted 578 hours to the appeal. Defendants argue that it was excessive to involve twelve new lawyers on the case, and that 578 hours was unnecessary as many of the legal issues involved had been fully researched and discussed for proceedings in this Court. Plaintiffs briefly claim that such a large number of attorneys and hours was necessary because of the “complexity of the case and the fact that the record is so voluminous.” In light of plaintiffs’ perfunctory explanation, the utilization of twelve new attorneys on appeal appears unreasonably excessive. As a remedy, defendants recommend a 50% reduction in fees for the extra twelve attorneys. Unless plaintiffs’ amended fee request includes a more complete explanation for the work on appeal, the Court will utilize this remedy.
I. Expenses
Defendants challenge plaintiffs’ request for expenses related to its team of investigators. Plaintiffs seek $15,000 for “its team of investigators and factual researchers who assisted counsel in securing documents, analyzing the administrative record, preparing a chronology of administrative action regarding AVA and document management services.” Plaintiffs identify these individuals by name, but have not supported this request with any details as to these individual’s activities other than to reference the times that they appear in the attorneys’ billing records. Thus, the Court has no basis for assessing the amount of time that these individuals devoted to this case, what they did, how much they were paid, and thus whether the requested reimbursement was reasonable. Therefore, unless they provide more complete documentation, plaintiffs' should not seek reimbursement for these expenses in the amended fee request.
J. Costs
Defendants contend that most of plaintiffs’ requested costs cannot be reimbursed. Under the EAJA, costs are limit
ed to those “enumerated in section 1920 of this title.” 28 U.S.C. § 2412(a)(1). As pertinent here, section 1920 limits recovery for costs to (1) fees of the clerk or marshal, (2) fees for transcripts, (3) fees for printing and witnesses, and (4) fees for copying. 28 U.S.C. §§ 1920(l)-(4). Plaintiffs, however, have sought costs for overhead, secretarial services, taxi fares, messenger costs, telephone bills, postage, meals, and travel, which are not compensable in this circuit.
See, e.g., Hirschey v. FERC, 111
F.2d 1, 6 (D.C.Cir.1985) (holding that taxi fares, overhead, and secretarial services cannot be reimbursed);
Mass. Fair Share v. Law Enforcement,
776 F.2d 1066, 1069 (D.C.Cir.1985) (holding that travel expenses, telephone bills, and postage are not compensable under EAJA). The only properly charged costs sought by plaintiffs are fees for copying and hearing transcripts. Thus, plaintiffs’ amended request for costs should be limited to only those costs.
CONCLUSION
The Court concludes that plaintiffs are entitled to fees and costs for litigating this action, including on appeal, because plaintiffs are the prevailing party and the government’s position was not substantially justified. Plaintiffs’ request for attorneys’ fees and costs, however, contains flaws that preclude the Court from determining the proper amount of fees and costs in this case. Therefore, plaintiffs’ motion for attorneys’ fees is DENIED without prejudice to reconsideration of an amended request in compliance with this opinion. Plaintiffs are directed to file an amended motion for attorneys’ fees in light of this opinion by no later than September 28, 2007. In the alternative, if the parties seek to negotiate a fee award, the parties shall file a joint status report and recommendation for future proceedings by no later than September 28, 2007. An appropriate Order accompanies this Memorandum Opinion.